Avaleht › 2. tüüpi diabeet › Florida
2. tüüpi diabeet kliinilised uuringud osariigis Florida
48 uuringut haiguse 2. tüüpi diabeet jaoks otsivad osalejaid osariigis Florida.
Linnad osariigis Florida
- Orlando24 uuringut
- Miami19 uuringut
- Jacksonville15 uuringut
- Hialeah10 uuringut
- Deltona10 uuringut
- Hollywood8 uuringut
- Miramar7 uuringut
- Pembroke Pines6 uuringut
- Boca Raton6 uuringut
- West Palm Beach6 uuringut
- Lakeland5 uuringut
- St. Petersburg5 uuringut
- Doral5 uuringut
- Tampa5 uuringut
- Clearwater4 uuringut
- Kendall4 uuringut
- Leesburg4 uuringut
- Cape Coral4 uuringut
- Davie4 uuringut
- Town 'n' Country4 uuringut
- Coral Springs3 uuringut
Ametlik uuringutekst (inglise keeles)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- Orlando Health, St. Petersburg
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT06906640Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- Orlando Health, St. Petersburg
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT06906627A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Omega Research Orlando, Altamonte Springs
- American Research Institute, Cutler Bay
- K2 Medical Research - Maitland, Maitland
- ja veel 1
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07783802Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Northeast Research Institute, Fleming Island
- AGA Clinical Trial, Hialeah
- Adult Medicine of Lake County, Inc, Mt. Dora
- ja veel 2
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Excel Medical Clinical Trials, Boca Raton
- Clinical Research of West Florida, Inc., Clearwater
- Beautiful Minds Clinical Research Center, Cutler Bay
- ja veel 32
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Clinical Research of West Florida, Inc., Clearwater
- Northeast Research Institute, Fleming Island
- Covenant Metabolic Specialists, LLC - Fort Myers, Fort Myers
- ja veel 12
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07754461A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects
- Clinical Pharmacology of Miami, Miami
- Progressive Medical Research, Port Orange
VärbamineFaas 1
Vanused 18–65 · Kõik sood · Uuendatud 29. sept 2026 · NCT07223333A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Flourish Medical Research, Boca Raton
- Apex Research, Cross City
- Evolution Research Center, Hialeah
- ja veel 12
VärbamineTerved vabatahtlikud oodatud
Vanused 55 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT06112418Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
- Clinical Pharmacology of Miami, Miami
VärbamineFaas 1
Vanused 18–65 · Kõik sood · Uuendatud 28. sept 2026 · NCT07399678A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Nature Coast Clinical Research, Crystal River
- West Coast Eye Institute, Lecanto
- South Broward Research, Miramar
- ja veel 3
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Jacksonville
- Research Site, Jacksonville
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07776509A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Arrow Clinical Trials, Daytona Beach
- Care Access - Delray Beach, Delray Beach
- Fleming Island Center for Clinical Research, Fleming Island
- ja veel 7
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Coral Gables
- Research Site, Fleming Island
- Research Site, Fort Lauderdale
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Boca Raton
- AURORA-2 Clinical Site, Daytona Beach
- AURORA-2 Clinical Site, Jacksonville
- ja veel 6
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743450A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- AES - DRS - Optimal Research Florida - Melbourne, Melbourne
- Tampa General Hospital, Tampa
- Conquest Research LLC - Winter Park, Winter Park
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 15. sept 2026 · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Tampa Bay Medical Research, Inc., Clearwater
- Center for Diabetes, Obesity and Metabolism Inc, Pembroke Pines
- Progressive Medical Research, Port Orange
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Renstar Medical Research, Ocala
- Oviedo Medical Research, Oviedo
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 14. sept 2026 · NCT06897475A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- Encore Medical Research LLC, Hollywood
- Bioclinical Research Alliance, Miami
- South Broward Research LLC, Miramar
- ja veel 2
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 11. sept 2026 · NCT07415954Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- D&H Doral Research Center, Doral
- AGA Clinical Trials, Hialeah
- Convenient Medical Center, Hialeah
- ja veel 13
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 11. sept 2026 · NCT07271186A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Encore Medical Research LLC, Hollywood
- South Broward Research LLC, Miramar
- Encore Medical Research of Weston, Weston
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 11. sept 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Crystal River
- Research Site, Hollywood
- Research Site, Jacksonville
- ja veel 3
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Velocity Clinical Research, New Smyrna Beach, Edgewater
- The Center for Diabetes and Endocrine Care, Fort Lauderdale
- Admed Research LLC, Miami
- ja veel 4
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07296484A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Encore Medical Research Boynton Beach, Boynton Beach
- Nemours Chld Clnc Jacksonville, Jacksonville
- Innovus Clinical, Kissimmee
- ja veel 2
VärbamineFaas 3
Vanused 10–18 · Kõik sood · Uuendatud 9. sept 2026 · NCT07282613A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Precision Clinical Research, Sunrise
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 8. sept 2026 · NCT07215559Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Optimus U Corporation, Miami
- San Marcus Research Clinic Inc, Miami Lakes
- Indago Research and Health Center, Miami Lakes
- ja veel 3
VärbamineFaas 3
Vanused 18–99 · Kõik sood · Uuendatud 3. sept 2026 · NCT07684144A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Fleming Island
- Research Site, Lauderdale Lakes
- Research Site, Leesburg
- ja veel 3
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. sept 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Innovative Research of W FL, Clearwater
- Nature Coast Clin Rsrch_Crystal River, Crystal River
- Florida Premier Cardiology, Delray Beach
- ja veel 15
VärbamineFaas 3
Vanused 45 ja vanemad · Kõik sood · Uuendatud 1. sept 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Lake City
- Research Site, Lakeland
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 31. aug 2026 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Jacksonville
- Research Site, Orlando
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 31. aug 2026 · NCT07662044A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Jacksonville
- Research Site, Lake City
- Research Site, Leesburg
- ja veel 1
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. aug 2026 · NCT07606066Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Accel Research Sites - DeLand, DeLand
- Charter Research, Orlando
- AdventHealth Translational Research Institute, Orlando
- ja veel 1
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 17. aug 2026 · NCT07527650Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
- AdventHealth Translational Research Institute, Orlando
VärbamineTerved vabatahtlikud oodatud
Vanused 25–55 · Kõik sood · Uuendatud 12. aug 2026 · NCT06993454A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Nemours Children's Health, Jacksonville
- D&H National Research Centers, Inc, Miami
- AdventHealth Orlando, Orlando
- ja veel 2
VärbamineFaas 3
Vanused 10–17 · Kõik sood · Uuendatud 7. aug 2026 · NCT06739122A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Doral
- Research Site, Ocoee
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. aug 2026 · NCT07664553A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
- Translational Clinical Research LLC, Aventura
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–75 · Kõik sood · Uuendatud 3. aug 2026 · NCT07590193Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Metabolic Research Institute, West Palm Beach
Värbamine
Vanused 18–75 · Kõik sood · Uuendatud 3. aug 2026 · NCT07521475Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Southwest General Healthcare Center, Fort Myers
- Panax Clinical Research, Miami Lakes
- Flourish Research Orlando, Winter Park
VärbamineFaas 2
Vanused 18–70 · Kõik sood · Uuendatud 15. juuni 2026 · NCT07502508DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- Johns Hopkins All Children's Hospital, St. Petersburg
VärbamineVaatlusuuring
Vanused 8–15 · Kõik sood · Uuendatud 7. mai 2026 · NCT06525259A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes
- Clinical Pharmacology of Miami, Miami
VärbamineFaas 1
Vanused 18–65 · Kõik sood · Uuendatud 6. mai 2026 · NCT07568678HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Universal Axon Clinical Research, Doral
- Velocity Clinical Research New Smyrna Beach, Edgewater
- Southwest General Healthcare Center, Fort Myers
- ja veel 3
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. apr 2026 · NCT07546929Allikas ClinicalTrials.gov, andmed saadud 4. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.